Abstract

Using nanopore sequencing, we showed the feasibility and impact of rapid genomic screening for managing thrombotic microangiopathies in 18 prospective cases, achieving diagnoses in <3 days. We compared the results with standard exome sequencing, cost efficiency, and complement blockade initiation.

1.
Fakhouri
F
,
Schwotzer
N
,
Frémeaux-Bacchi
V
.
How I diagnose and treat atypical hemolytic uremic syndrome
.
Blood
.
2023
;
141
(
9
):
984
-
995
.
2.
Doreille
A
,
Rafat
C
,
Rondeau
E
,
Mesnard
L
.
How I treat thrombotic microangiopathy in the era of rapid genomics
.
Blood
.
2023
;
141
(
2
):
147
-
155
.
3.
Froese
DS
,
Kopec
J
,
Fitzpatrick
F
, et al
.
Structural insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking
.
J Biol Chem
.
2015
;
290
(
49
):
29167
-
29177
.
4.
Nester
CM
,
Barbour
T
,
de Cordoba
SR
, et al
.
Atypical aHUS: state of the art
.
Mol Immunol
.
2015
;
67
(
1
):
31
-
42
.
5.
Zipfel
PF
,
Edey
M
,
Heinen
S
, et al
.
Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
.
PLoS Genet
.
2007
;
3
(
3
):
e41
.
6.
Zipfel
PF
,
Wiech
T
,
Stea
ED
,
Skerka
C
.
CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy
.
J Am Soc Nephrol
.
2020
;
31
(
2
):
241
-
256
.
7.
García-Fernández
J
,
Vilches-Arroyo
S
,
Olavarrieta
L
,
Pérez-Pérez
J
,
Rodríguez de Córdoba
S
.
Detection of genetic rearrangements in the regulators of complement activation RCA cluster by high-throughput sequencing and MLPA
.
Methods Mol Biol
.
2021
;
2227
:
159
-
178
.
8.
Gorzynski
JE
,
Goenka
SD
,
Shafin
K
, et al
.
Ultrarapid nanopore genome sequencing in a critical care setting
.
N Engl J Med
.
2022
;
386
(
7
):
700
-
702
.
9.
Payne
A
,
Holmes
N
,
Clarke
T
,
Munro
R
,
Debebe
BJ
,
Loose
M
.
Readfish enables targeted nanopore sequencing of gigabase-sized genomes
.
Nat Biotechnol
.
2021
;
39
(
4
):
442
-
450
.
10.
Weilguny
L
,
De Maio
N
,
Munro
R
, et al
.
Dynamic, adaptive sampling during nanopore sequencing using Bayesian experimental design
.
Nat Biotechnol
.
2023
;
41
(
7
):
1018
-
1025
.
11.
Challis
RC
,
Araujo
GSR
,
Wong
EKS
, et al
.
A de novo deletion in the regulators of complement activation cluster producing a hybrid complement factor H/complement factor H–related 3 gene in atypical hemolytic uremic syndrome
.
J Am Soc Nephrol
.
2016
;
27
(
6
):
1617
-
1624
.
12.
Erger
F
,
Aryal
RP
,
Reusch
B
, et al
.
Germline C1GALT1C1 mutation causes a multisystem chaperonopathy
.
Proc Natl Acad Sci U S A
.
2023
;
120
(
22
):
e2211087120
.
13.
Vivarelli
M
,
Barratt
J
,
Beck
LH
, et al
.
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
.
Kidney Int
.
2024
;
106
(
3
):
369
-
391
.
14.
Brocklebank
V
,
Walsh
PR
,
Smith-Jackson
K
, et al
.
Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study
.
Blood
.
2023
;
142
(
16
):
1371
-
1386
.
15.
Wetterstrand
KA
.
DNA Sequencing Costs: Data. National Institutes of Health, National Human Genome Research Institute; 2022
. Accessed 23 February 2024. https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data.
16.
Nobile
G
,
Doreille
A
,
Raymond
L
, et al
.
Role of the I416L variant of complement factor I in thrombotic microangiopathy among patients of African ancestry
.
Kidney Int Rep
.
2023
;
8
(
10
):
2136
-
2140
.
17.
Schwotzer
N
,
Fakhouri
F
,
Martins
PV
, et al
.
Hot spot of complement factor I rare variant p.Ile357Met in patients with hemolytic uremic syndrome
.
Am J Kidney Dis
.
2024
;
84
(
2
):
244
-
249
.
18.
Doreille
A
,
Raymond
L
,
Lebre
A-S
, et al
.
Nephronophthisis in young adults phenocopying thrombotic microangiopathy and severe nephrosclerosis
.
Clin J Am Soc Nephrol
.
2021
;
16
(
4
):
615
-
617
.
19.
Amemiya
HM
,
Kundaje
A
,
Boyle
AP
.
The ENCODE blacklist: identification of problematic regions of the genome
.
Sci Rep
.
2019
;
9
(
1
):
9354
.
You do not currently have access to this content.
Sign in via your Institution